<DOC>
	<DOCNO>NCT00073593</DOCNO>
	<brief_summary>The purpose study examine safety efficacy Angiomax alternative anticoagulant heparin protamine reversal patient undergo off-pump coronary artery bypass graft surgery .</brief_summary>
	<brief_title>Comparing Angiomax Heparin With Protamine Reversal Patients OPCAB</brief_title>
	<detailed_description />
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<mesh_term>Protamines</mesh_term>
	<criteria>Inclusion : Provide write informed consent initiation study related procedure . Be least 18 year age . Be accept elective offpump coronary artery bypass graft ( CABG ) surgery without concomitant cardiac surgical procedure . &lt; 4 plan Coronary Artery Bypass Grafts Exclusion : Any prior CardioThoracic Surgical procedure require median sternotomy Confirmed pregnancy baseline urine serum pregnancy test ( woman childbearing potential ) . Cerebrovascular accident within 6 month randomization , cerebrovascular accident residual neurological deficit . Intracranial neoplasm , arteriovenous malformation , aneurysm . Dependency renal dialysis creatinine clearance &lt; 30mL/min . Ongoing treatment warfarin ( oral anticoagulant ) time randomization . Patients previously treat warfarin may enrol warfarin therapy safely discontinue baseline INR &lt; 1.3 time control absence heparin therapy . Known allergy Angiomax hirudin derive drug , know sensitivity component product . Patients receive clopidogrel within previous 5 day randomization . Patients receive glycoprotein IIb/IIIa inhibitor within 48 hour abciximab ( ReoPro ) within 24 hour eptifibatide ( Integrilin ) tirofiban ( Aggrastat ) randomization Patients receive lepirudin argatroban within previous 24 hour randomization . Patients receive low molecular weight heparin ( LMWH ) thrombolytic within previous 12 hour unfractionated heparin within 30 minute randomization . Patients active prior history heparininduced thrombocytopenia ( HIT ) /heparininduced thrombocytopenia thrombosis syndrome ( HITTS ) * . Participation clinical research study involve evaluation investigational drug device within 30 day randomization . Refusal undergo blood transfusion become necessary . Any disease condition , , judgment investigator would place patient undue risk enrol trial inability comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Off-Pump Coronary Artery Bypass Graft Surgery</keyword>
	<keyword>CABG</keyword>
	<keyword>OPCAB</keyword>
	<keyword>Heparin</keyword>
	<keyword>Patients require off-pump CABG</keyword>
</DOC>